• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型眼部药物传递系统:微乳的最新进展。

Novel Ocular Drug Delivery Systems: An Update on Microemulsions.

机构信息

Department of Pharmaceutical Technology, Faculty of Pharmacy, University of Health Sciences, Istanbul, Turkey.

Department of Pharmaceutical Technology, Faculty of Pharmacy, Istanbul University, Istanbul, Turkey.

出版信息

J Ocul Pharmacol Ther. 2020 Jul/Aug;36(6):342-354. doi: 10.1089/jop.2019.0135. Epub 2020 Apr 7.

DOI:10.1089/jop.2019.0135
PMID:32255728
Abstract

Sufficient ophthalmic drug delivery is still challenging for pharmaceutical technologists, despite various scientific efforts. Several ocular drug carriers have been designed to enhance bioavailability by prolonging the drug retention time. One of the current encouraging approaches is the utilization of colloidal carriers with the characteristic submicron-nanometer size. Microemulsions (MEs) are such colloid systems that present sizes between 5 and 200 nm with significant thermodynamic stability and low surface tension. In addition, MEs as topical ocular carriers can lead to great ocular drug adsorption due to their enhanced retention time. Furthermore, considering that MEs are stable for long time and various temperatures, their ocular application is of great interest. The aim of this study is to cover basic physicochemical principals of ocular MEs such as their possible size, stability, and therapeutic efficacy against various eye disorders. Thus, a comprehensive review for ocular drug delivery systems in the form of MEs that show promising characteristics as their stability and therapeutic efficiency is performed.

摘要

尽管已经有了各种科学努力,但对于制药技术人员来说,仍然难以充分将药物输送到眼部。已经设计了几种眼部药物载体,通过延长药物滞留时间来提高生物利用度。目前令人鼓舞的方法之一是利用具有亚微米-纳米级特征的胶体载体。微乳液(MEs)就是这样的胶体系统,其粒径在 5 至 200nm 之间,具有显著的热力学稳定性和低表面张力。此外,由于 MEs 具有增强的滞留时间,因此作为局部眼部载体,它们可以导致药物在眼部的大量吸附。此外,考虑到 MEs 在长时间和各种温度下都稳定,因此它们的眼部应用非常有意义。本研究的目的是涵盖眼部 MEs 的基本物理化学原理,例如其可能的粒径、稳定性和对各种眼部疾病的治疗效果。因此,对以稳定性和治疗效果为特点的眼部药物传递系统进行了综述。

相似文献

1
Novel Ocular Drug Delivery Systems: An Update on Microemulsions.新型眼部药物传递系统:微乳的最新进展。
J Ocul Pharmacol Ther. 2020 Jul/Aug;36(6):342-354. doi: 10.1089/jop.2019.0135. Epub 2020 Apr 7.
2
Micelles: Promising Ocular Drug Carriers for Anterior and Posterior Segment Diseases.胶束:用于前节和后节疾病的有前途的眼部药物载体。
J Ocul Pharmacol Ther. 2020 Jul/Aug;36(6):323-341. doi: 10.1089/jop.2019.0109. Epub 2020 Apr 20.
3
Recent advances in ocular drug delivery.眼部药物输送的最新进展。
Drug Dev Ind Pharm. 2013 Nov;39(11):1599-617. doi: 10.3109/03639045.2012.736515. Epub 2012 Nov 16.
4
Nanostructured lipid carriers as novel ophthalmic delivery system for mangiferin: improving in vivo ocular bioavailability.纳米结构脂质载体作为一种新型的芒果苷眼部给药系统:提高体内眼生物利用度。
J Pharm Sci. 2012 Oct;101(10):3833-44. doi: 10.1002/jps.23251. Epub 2012 Jul 5.
5
Microemulsions as ocular drug delivery systems: recent developments and future challenges.微乳剂作为眼部给药系统:最新进展与未来挑战。
Prog Retin Eye Res. 2002 Jan;21(1):15-34. doi: 10.1016/s1350-9462(01)00017-9.
6
Applications of Nanotechnology-mediated Herbal Nanosystems for Ophthalmic Drug.纳米技术介导的草药纳米系统在眼科药物中的应用。
Pharm Nanotechnol. 2024;12(3):229-250. doi: 10.2174/2211738511666230816090046.
7
Polymeric micelles for ocular drug delivery: From structural frameworks to recent preclinical studies.用于眼部给药的聚合物胶束:从结构框架到近期临床前研究
J Control Release. 2017 Feb 28;248:96-116. doi: 10.1016/j.jconrel.2017.01.012. Epub 2017 Jan 11.
8
Nanoparticle-Based Topical Ophthalmic Gel Formulation for Sustained Release of Hydrocortisone Butyrate.用于丁酸氢化可的松缓释的基于纳米颗粒的局部用眼科凝胶制剂
AAPS PharmSciTech. 2016 Apr;17(2):294-306. doi: 10.1208/s12249-015-0354-5. Epub 2015 Jun 18.
9
Development of microemulsions for ocular delivery.用于眼部给药的微乳剂的研发。
Ther Deliv. 2017 Mar;8(5):313-330. doi: 10.4155/tde-2016-0076.
10
Enhanced ocular bioavailability of fluconazole from niosomal gels and microemulsions: formulation, optimization, and in vitro-in vivo evaluation.增强型氟康唑纳米囊和微乳凝胶的眼部生物利用度:制剂、优化和体外-体内评价。
Pharm Dev Technol. 2019 Jan;24(1):48-62. doi: 10.1080/10837450.2017.1413658. Epub 2017 Dec 14.

引用本文的文献

1
Progress in Nanotechnology for Treating Ocular Surface Chemical Injuries: Reflecting on Advances in Ophthalmology.用于治疗眼表化学伤的纳米技术进展:眼科进展反思
Adv Sci (Weinh). 2025 Feb;12(6):e2407340. doi: 10.1002/advs.202407340. Epub 2025 Jan 4.
2
Controlled Release of Molecules to Enhance Cell Survival and Regeneration.分子控释以增强细胞存活和再生。
Methods Mol Biol. 2025;2848:259-267. doi: 10.1007/978-1-0716-4087-6_16.
3
Expanding Arsenal against Ocular Diseases through Nanoemulsion: Success So Far and the Road Ahead.
通过纳米乳剂扩展抗眼部疾病的武器库:迄今为止的成功与未来之路。
Curr Drug Deliv. 2024 Jul 15. doi: 10.2174/0115672018286288240705064730.
4
Development of Osthole-Loaded Microemulsions as a Prospective Ocular Delivery System for the Treatment of Corneal Neovascularization: In Vitro and In Vivo Assessments.蛇床子素微乳剂作为治疗角膜新生血管的前瞻性眼用给药系统的研发:体外和体内评估
Pharmaceuticals (Basel). 2023 Sep 22;16(10):1342. doi: 10.3390/ph16101342.
5
Recent advances in medicinal compounds related to corneal crosslinking.与角膜交联相关的药用化合物的最新进展。
Front Pharmacol. 2023 Sep 29;14:1232591. doi: 10.3389/fphar.2023.1232591. eCollection 2023.
6
Preparation of a Sunitinib loaded microemulsion for ocular delivery and evaluation for the treatment of corneal neovascularization and .用于眼部给药的载有舒尼替尼的微乳剂的制备及其治疗角膜新生血管的评估
Front Pharmacol. 2023 Jul 11;14:1157084. doi: 10.3389/fphar.2023.1157084. eCollection 2023.
7
Exploring the Versatility of Microemulsions in Cutaneous Drug Delivery: Opportunities and Challenges.探索微乳剂在皮肤给药中的多功能性:机遇与挑战。
Nanomaterials (Basel). 2023 May 21;13(10):1688. doi: 10.3390/nano13101688.
8
Updates on Biodegradable Formulations for Ocular Drug Delivery.眼部给药用可生物降解制剂的研究进展
Pharmaceutics. 2023 Feb 22;15(3):734. doi: 10.3390/pharmaceutics15030734.
9
as a Prediction Platform for Nanotechnology-Based Strategies: Insights on Analytical Challenges.作为基于纳米技术策略的预测平台:对分析挑战的见解
Toxics. 2023 Mar 1;11(3):239. doi: 10.3390/toxics11030239.
10
Ocular Delivery of Quercetin Using Microemulsion System: Design, Characterization, and Ex-vivo Transcorneal Permeation.使用微乳剂系统进行槲皮素的眼部给药:设计、表征及离体角膜渗透
Iran J Pharm Res. 2022 Aug 20;21(1):e127486. doi: 10.5812/ijpr-127486. eCollection 2022 Dec.